Research Paper Volume 13, Issue 3 pp 4096—4114

Expression and prognostic analyses of SCAMPs in pancreatic adenocarcinoma

Co-expressed genes of SCAMP1, 5, and correction between SCAMP1- 5 in PAAD (cBioPortal for Cancer Genomics, LinkedOmics, and GEPIA). (A) Co-expressed genes (top-1) of SCAMP1, 5 in PAAD using the cBioPortal for Cancer Genomics. (I: TMED7, II: DAZAP1, III: BEX1, IV: TGIF1) (B, C) Correction between SCAMP1- 5 in PAAD using LinkedOmics. (B: I: SCAMP1 vs 2, II: SCAMP1 vs 3 III: SCAMP1 vs 4, IV: SCAMP1 vs 5, V: SCAMP2 vs 3; C: I: SCAMP2 vs 4, II: SCAMP2 vs 5 III: SCAMP3 vs 4, IV: SCAMP3 vs 5, V: SCAMP4 vs 5). (D, E) Correction between SCAMP1- 5 in PAAD using GEPIA. (R: Spearman correlation analysis; B: I: SCAMP1 vs 2, II: SCAMP1 vs 3 III: SCAMP1 vs 4, IV: SCAMP1 vs 5, V: SCAMP2 vs 3; C: I: SCAMP2 vs 4, II: SCAMP2 vs 5 III: SCAMP3 vs 4, IV: SCAMP3 vs 5, V: SCAMP4 vs 5) * Spearman correlation >0.3 or Spearman correlation

Figure 5. Co-expressed genes of SCAMP1, 5, and correction between SCAMP1- 5 in PAAD (cBioPortal for Cancer Genomics, LinkedOmics, and GEPIA). (A) Co-expressed genes (top-1) of SCAMP1, 5 in PAAD using the cBioPortal for Cancer Genomics. (I: TMED7, II: DAZAP1, III: BEX1, IV: TGIF1) (B, C) Correction between SCAMP1- 5 in PAAD using LinkedOmics. (B: I: SCAMP1 vs 2, II: SCAMP1 vs 3 III: SCAMP1 vs 4, IV: SCAMP1 vs 5, V: SCAMP2 vs 3; C: I: SCAMP2 vs 4, II: SCAMP2 vs 5 III: SCAMP3 vs 4, IV: SCAMP3 vs 5, V: SCAMP4 vs 5). (D, E) Correction between SCAMP1- 5 in PAAD using GEPIA. (R: Spearman correlation analysis; B: I: SCAMP1 vs 2, II: SCAMP1 vs 3 III: SCAMP1 vs 4, IV: SCAMP1 vs 5, V: SCAMP2 vs 3; C: I: SCAMP2 vs 4, II: SCAMP2 vs 5 III: SCAMP3 vs 4, IV: SCAMP3 vs 5, V: SCAMP4 vs 5) * Spearman correlation >0.3 or Spearman correlation< -0.3 and p< 0.05.